Innovative Eyewear (NASDAQ: LUCY) officer may sell $14,839 in RSU shares

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) had a notice filed under Rule 144 for a planned sale of its common stock by officer Konrad Dabrowski. Up to 20,900 shares may be sold through Raymond James & Associates, Inc. on Nasdaq, with an aggregate market value of $14,839.00. The shares relate to an RSU Grant, and total common shares outstanding are listed as 6,403,728, a baseline figure rather than the amount being sold.

Key Figures

Shares to be sold: 20,900 shares Aggregate market value: $14,839.00 Shares outstanding: 6,403,728 shares +2 more

5 metrics

Shares to be sold 20,900 shares Maximum common shares covered by the Rule 144 notice

Aggregate market value $14,839.00 Estimated total value of 20,900 shares subject to potential sale

Shares outstanding 6,403,728 shares Total Innovative Eyewear Inc common shares outstanding as listed in the filing

Planned sale date 08/19/2026 Date associated with the potential sale of common shares

Acquisition description RSU Grant Type of grant related to the common shares to be sold

Key Terms

Rule 144, RSU Grant, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer"

attorney-in-fact regulatory

"as attorney-in-fact for Konrad Dabrowski"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing mean for Innovative Eyewear Inc (LUCY)?

The Form 144 indicates an officer of Innovative Eyewear Inc may sell 20,900 common shares under Rule 144. It is a notice of potential resale of restricted or control securities, not a commitment that all shares will actually be sold.

How many LUCY shares are covered by this Rule 144 notice?

The notice covers up to 20,900 shares of Innovative Eyewear Inc common stock. This is the maximum amount the reporting person may sell under this specific filing, subject to Rule 144 conditions and market execution through the named broker.

What is the aggregate market value of the LUCY shares in this Form 144?

The filing lists an aggregate market value of $14,839.00 for the 20,900 Innovative Eyewear Inc shares. This figure reflects the estimated total value for the potential sale, based on pricing at the time the notice was prepared.

How many Innovative Eyewear Inc (LUCY) shares are outstanding in this filing?

The filing states that 6,403,728 shares of Innovative Eyewear Inc common stock are outstanding. This number provides context for the company’s total equity base and is separate from the 20,900 shares covered by the planned Rule 144 sale.

Who is selling LUCY shares under this Form 144 and through which broker?

The planned sale is for the account of Konrad Dabrowski, an officer of Innovative Eyewear Inc. The notice identifies Raymond James & Associates, Inc. as the broker handling any sales on Nasdaq pursuant to this Rule 144 filing.

What is the origin of the LUCY shares to be sold under this Rule 144?

The securities information describes the shares as tied to an RSU Grant from the issuer. This indicates the potential sale involves equity previously granted as restricted stock units to the officer, rather than shares bought in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 07:44 AM Accepted by SEC EDGAR 08/20/2026 - 07:43 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001906013
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Dabrowski Konrad
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg FL 33716	20900	14839.00	6403728	08/19/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			20900	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Konrad Dabrowski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)